English (United Kingdom)French (Fr)
Home Wellness Articles Informed Choice Chicken Pox Vaccine

Chicken Pox Vaccine

Written by Jim Davis, D.C., F.I.C.P.A.   
Tuesday, 07 October 2008 12:27
Article Index
Chicken Pox Vaccine
Page 2
All Pages

Chicken pox is usually a mild disease in children. However, the push to mandate this vaccine for a relatively harmless disease of childhood (90 % of cases are in children < 10 years of age who have mild and rarely severe complications), stems from the high complications and mortality rate among high risk individuals. These groups of people are for whom the vaccine was originally designed. Those groups include children with leukemia or persons receiving steroids (given to persons with cancer, organ transplants, kidney disease and asthma.) Steroids are known to be immuno-supressors, leaving some people defenseless against what would normally be harmless diseases (9). These immuno-suppressed persons comprise only .1% of all chicken pox cases, yet constitutes the majority of chicken pox complications.(1,2,3)

Adults are another high risk group for complications from chicken pox. Adults comprise only 2% of chicken pox cases, but are responsible for 55% of deaths.

When an individual contracts the "wild" chicken pox virus, they develop a lifelong immunity to the disease. A question that should be asked is: do children who get the vaccine develop the same lifetime immunity? The answer is no one knows. The question remains as to whether mass vaccination in childhood will cause the disease to be delayed into adulthood where it will cause many more deaths and complications. A recent study looked at the results of 20 years of varicella vaccine use in Japan. It states "the incidence of adult varicella in Japan is increasing with substantial social cost"(4). Even Merck, the manufacturer of the vaccine states "the duration of protection of Varivax (chicken pox vaccine) is unknown at present" and "in a highly vaccinated population immunity for some individuals may wane". Merck also admits: "no placebo controlled trial was carried out with Varivax using the current vaccine" and "there is insufficient data to access the rate of protection against the complications (eg. encephalitis, hepatitis, pneumonia) in children". It also states the same for adults(5). This is a remarkable admission. The purpose of vaccinating every child is to avoid complications from the chicken pox. If we don't know whether or not it prevents these complications, why would it be given to healthy children?

Besides the obvious lack of knowledge on protection against complications from the chicken pox vaccine and by quite possibly causing more harm by delaying the disease until adulthood, we should investigate the most current data regarding what should matter most: deaths related to chicken pox.

According to Morbidity and Mortality Weekly Report (MMWR) published by the CDC 45% of all chicken pox related deaths occur in children. Using the most current data available: four years prior to vaccination with varicella vaccine an average of 46 children died per year due to chicken pox complications. Since the mass inoculation of children with Varivax there have been and average of 42 deaths per year from complications from the disease. However, one should also include reports of adverse effects of the vaccine for an accurate comparison. According to information from the Vaccine Adverse Event Reporting System (VAERS) since 1999 there have been an average of 10 deaths per year associated with the varicella vaccine. Pre-varicella vaccine: 42 deaths per year. Post varicella vaccine: 52 deaths per year. This is astonishing especially when one looks at the FDA's admission that only 1-10% of all adverse reactions are ever reported. The 10 vaccine deaths could be 100-1000 deaths considering the vast under reporting according to the FDA.